Norden Group’s Bristol-Myers Squibb BMY Stock Holding History

Norden Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.2M	Buy	200,824 +23,909	+14%	+$1.39M	1.17%	12
2025 Q4	$9.54M	Buy	176,915 +157,604	+816%	+$7.58M	0.93%	17
2025 Q3	$871K	Sell	19,311 -375	-2%	-$17.5K	0.09%	221
2025 Q2	$911K	Sell	19,686 -73,134	-79%	-$3.59M	0.1%	202
2025 Q1	$5.66M	Buy	92,820 +744	+0.8%	+$43.4K	0.65%	27
2024 Q4	$5.21M	Buy	92,076 +70,423	+325%	+$3.93M	0.59%	33
2024 Q3	$1.12M	Buy	21,653 +11,158	+106%	+$523K	0.13%	170
2024 Q2	$436K	Sell	10,495 -3,351	-24%	-$150K	0.09%	240
2024 Q1	$751K	Buy	13,846 +3,213	+30%	+$164K	0.15%	153
2023 Q4	$546K	Buy	10,633 +773	+8%	+$40.6K	0.09%	137
2023 Q3	$572K	Buy	+9,860	New	+$604K	0.19%	121

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norden Group's BMY Position: Q1 2026 in Review

Norden Group increased its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, buying an estimated $1.39M and bringing the position to 200,824 shares worth $12.2M. The position accounts for 1.17% of the portfolio, ranked #12.

Norden Group first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Norden Group held 200,824 shares of Bristol-Myers Squibb worth $12.2M as of Q1 2026.
Norden Group bought 23,909 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.39M.
Bristol-Myers Squibb made up 1.17% of Norden Group's portfolio in Q1 2026, its #12 holding.
Norden Group first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.